LMAT LeMaitre Vascular Inc

$87.93

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 11/21/2025

About LeMaitre Vascular Inc

LeMaitre Vascular, Inc. designs, markets, sells, services and supports medical devices and implants for the treatment of peripheral vascular diseases worldwide. The company is headquartered in Burlington, Massachusetts.

Website: https://www.lemaitre.com

Sector
LIFE SCIENCES
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1158895
Address
63 SECOND AVENUE, BURLINGTON, MA, US
Valuation
Market Cap
$1.95B
P/E Ratio
44.70
PEG Ratio
2.27
Price to Book
5.77
Performance
EPS
$1.93
Dividend Yield
0.93%
Profit Margin
20.00%
ROE
13.90%
Technicals
50D MA
$88.78
200D MA
$91.40
52W High
$109.31
52W Low
$61.90
Fundamentals
Shares Outstanding
23M
Target Price
$105.62
Beta
0.88

LMAT EPS Estimates vs Actual

● Estimated
● Actual

LMAT News & Sentiment

Nov 14, 2025 • Zacks Commentary NEUTRAL
New Strong Buy Stocks for November 14th
NPSNY, SUZ, EVCM, LMAT and TER have been added to the Zacks Rank #1 (Strong Buy) List on ...
Nov 12, 2025 • Benzinga NEUTRAL
LeMaitre to Participate in Upcoming Investor Conferences - LeMaitre Vascular ( NASDAQ:LMAT )
BURLINGTON, Mass., Nov. 12, 2025 ( GLOBE NEWSWIRE ) -- LeMaitre Vascular, Inc. ( NASDAQ:LMAT ) announced today that management will participate in three upcoming investor conferences. Tuesday, November 18, 2025 Waldorf Hilton, London Dorian LeBlanc, CFO, will present at 8:00 AM GMT
Nov 12, 2025 • GlobeNewswire NEUTRAL
LeMaitre to Participate in Upcoming Investor Conferences
BURLINGTON, Mass., Nov. 12, 2025 ( GLOBE NEWSWIRE ) -- LeMaitre Vascular, Inc. ( Nasdaq:LMAT ) announced today that management will participate in three upcoming investor conferences.
Nov 11, 2025 • Zacks Commentary BULLISH
3 Reasons Why Growth Investors Shouldn't Overlook LeMaitre ( LMAT )
LeMaitre (LMAT) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Nov 07, 2025 • Zacks Commentary NEUTRAL
LeMaitre Vascular ( LMAT ) Q3 Earnings Surpass Estimates
LeMaitre (LMAT) delivered earnings and revenue surprises of +8.77% and -2.03%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Nov 03, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Can Strength in Rental Business Drive INFU Stock Before Q3 Earnings?
InfuSystem eyes third-quarter 2025 gains as rental contracts and ERP upgrades boost margins across Patient Services and Device Solutions.
Sentiment Snapshot

Average Sentiment Score:

0.105
50 articles with scored sentiment

Overall Sentiment:

Neutral

LMAT Reported Earnings

Aug 05, 2025
Jun 30, 2025 (Pre market)
0.03 Surprise
  • Reported EPS: $0.60
  • Estimate: $0.57
  • Whisper: —
  • Surprise %: 5.9%
May 01, 2025
Mar 31, 2025 (Pre market)
-0.02 Surprise
  • Reported EPS: $0.48
  • Estimate: $0.50
  • Whisper: —
  • Surprise %: -3.6%
Feb 27, 2025
Dec 31, 2024 (Post market)
0.0 Surprise
  • Reported EPS: $0.49
  • Estimate: $0.49
  • Whisper: —
  • Surprise %: 0.0%
Oct 31, 2024
Sep 30, 2024 (Post market)
0.05 Surprise
  • Reported EPS: $0.49
  • Estimate: $0.44
  • Whisper: —
  • Surprise %: 11.4%
Aug 01, 2024
Jun 30, 2024 (Post market)
0.05 Surprise
  • Reported EPS: $0.52
  • Estimate: $0.47
  • Whisper: —
  • Surprise %: 10.6%
May 02, 2024
Mar 31, 2024 (Post market)
0.05 Surprise
  • Reported EPS: $0.44
  • Estimate: $0.39
  • Whisper: —
  • Surprise %: 12.8%
Feb 27, 2024
Dec 31, 2023 (Post market)
0.02 Surprise
  • Reported EPS: $0.38
  • Estimate: $0.36
  • Whisper: —
  • Surprise %: 5.6%
Nov 01, 2023
Sep 30, 2023 (Post market)
0.03 Surprise
  • Reported EPS: $0.33
  • Estimate: $0.30
  • Whisper: —
  • Surprise %: 10.0%
Aug 01, 2023
Jun 30, 2023 (Post market)
0.04 Surprise
  • Reported EPS: $0.36
  • Estimate: $0.32
  • Whisper: —
  • Surprise %: 12.5%

Financials